These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
600 related items for PubMed ID: 18087663
1. Transforming growth factor-beta1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture. Naim R, Naumann A, Barnes J, Sauter A, Hormann K, Merkel D, Aust W, Braun T, Bloching M. Aesthetic Plast Surg; 2008 Mar; 32(2):346-52. PubMed ID: 18087663 [Abstract] [Full Text] [Related]
3. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M, Muragaki Y, Ooshima A. Arch Dermatol Res; 2005 Oct 15; 297(4):161-9. PubMed ID: 16184401 [Abstract] [Full Text] [Related]
4. Effect of transforming growth factor-beta1 antisense oligonucleotides on matrix metalloproteinases and their inhibitors in keloid fibroblasts. Bran GM, Goessler UR, Baftiri A, Hormann K, Riedel F, Sadick H. Otolaryngol Head Neck Surg; 2010 Jul 15; 143(1):66-71. PubMed ID: 20620621 [Abstract] [Full Text] [Related]
5. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region. Inoue T, Nabeshima K, Shimao Y, Koono M. Biochem Biophys Res Commun; 1999 Jun 24; 260(1):225-31. PubMed ID: 10381371 [Abstract] [Full Text] [Related]
6. TGF-ß1 antisense impacts the SMAD signalling system in fibroblasts from keloid scars. Bran GM, Sommer UJ, Goessler UR, Hörmann K, Riedel F, Sadick H. Anticancer Res; 2010 Sep 24; 30(9):3459-63. PubMed ID: 20944123 [Abstract] [Full Text] [Related]
7. Mechanism of regulation of HGF/SF gene expression in fibroblasts by TGF-beta1. Harrison P, Bradley L, Bomford A. Biochem Biophys Res Commun; 2000 Apr 29; 271(1):203-11. PubMed ID: 10777703 [Abstract] [Full Text] [Related]
8. Hepatocyte growth factor suppresses transforming growth factor-beta-1 and type III collagen in human primary renal fibroblasts. Mou S, Wang Q, Shi B, Gu L, Ni Z. Kaohsiung J Med Sci; 2009 Nov 29; 25(11):577-87. PubMed ID: 19858036 [Abstract] [Full Text] [Related]
9. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Ann Plast Surg; 1999 Aug 29; 43(2):179-84. PubMed ID: 10454326 [Abstract] [Full Text] [Related]
10. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts. Zhang GY, Yi CG, Li X, Ma B, Li ZJ, Chen XL, Guo SZ, Gao WY. Br J Dermatol; 2009 Apr 29; 160(4):762-70. PubMed ID: 19120328 [Abstract] [Full Text] [Related]
11. Differential gene expression in response to transforming growth factor-beta1 by fetal and postnatal dermal fibroblasts. Rolfe KJ, Irvine LM, Grobbelaar AO, Linge C. Wound Repair Regen; 2007 Apr 29; 15(6):897-906. PubMed ID: 18028139 [Abstract] [Full Text] [Related]
12. Gene expression of transforming growth factor-beta1 and hepatocyte growth factor during wound healing of injured rat vocal fold. Ohno T, Hirano S, Rousseau B. Laryngoscope; 2009 Apr 29; 119(4):806-10. PubMed ID: 19213039 [Abstract] [Full Text] [Related]
13. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation. Brenner M, Degitz K, Besch R, Berking C. Br J Dermatol; 2005 Oct 29; 153(4):733-9. PubMed ID: 16181453 [Abstract] [Full Text] [Related]
14. The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA. J Am Coll Surg; 2005 Sep 29; 201(3):391-7. PubMed ID: 16125072 [Abstract] [Full Text] [Related]
15. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1. Xie JL, Qi SH, Pan S, Xu YB, Li TZ, Liu XS, Liu P. Dermatol Surg; 2008 Sep 29; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749 [Abstract] [Full Text] [Related]
16. Smad interacting protein 1 as a regulator of skin fibrosis in pathological scars. Zhang ZF, Zhang YG, Hu DH, Shi JH, Liu JQ, Zhao ZT, Wang HT, Bai XZ, Cai WX, Zhu HY, Tang CW. Burns; 2011 Jun 29; 37(4):665-72. PubMed ID: 21236582 [Abstract] [Full Text] [Related]
17. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts. Fan SQ, Cai JL, Qin LY, Wang ZH, Liu ZZ, Sun ML. Ann Plast Surg; 2008 Mar 29; 60(3):299-305. PubMed ID: 18443513 [Abstract] [Full Text] [Related]
18. Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells. Roletto F, Galvani AP, Cristiani C, Valsasina B, Landonio A, Bertolero F. J Cell Physiol; 1996 Jan 29; 166(1):105-11. PubMed ID: 8557758 [Abstract] [Full Text] [Related]
19. [The expression of periostin in hyperplasic scars and the relations to TGF-beta1 and its receptors]. Wang Q, Nie FF, Zhao X, Qin ZL. Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May 29; 23(3):229-32. PubMed ID: 17649947 [Abstract] [Full Text] [Related]